Amanote Research

Amanote Research

    RegisterSign In

Current Treatment of AL Amyloidosis

Haematologica - Italy
doi 10.3324/haematol.2009.008912
Full Text
Open PDF
Abstract

Available in full text

Categories
Hematology
Date

July 30, 2009

Authors
G. PalladiniG. Merlini
Publisher

Ferrata Storti Foundation (Haematologica)


Related search

Aggregation in AL Amyloidosis

Biophysical Journal
Biophysics
2014English

News in AL Amyloidosis ASH 2016

Memo - Magazine of European Medical Oncology
OncologyHematology
2017English

New and Developing Therapies for AL Amyloidosis

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2016English

AL Amyloidosis Complicated by Persistent Oral Bleeding

Case Reports in Hematology
2015English

A Second Course of High-Dose Melphalan and Auto-SCT for the Treatment of Relapsed AL Amyloidosis

Bone Marrow Transplantation
TransplantationHematology
2010English

AL Amyloidosis With Non-Amyloid Forming Monoclonal Immunoglobulin Deposition; A Case Mimicking AHL Amyloidosis

BMC Nephrology
Nephrology
2018English

Daratumumab Proves Safe and Highly Effective in AL Amyloidosis

British Journal of Haematology
Hematology
2018English

Acquired Factor X Deficiency Associated With Atypical AL-amyloidosis

Internal Medicine
Internal MedicineMedicine
2014English

The Occurrence of AL Amyloidosis (Light-Chain Amyloidosis) in Patients With Multiple Myeloma in Lower Silesia Region, Poland

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy